Literature DB >> 21517800

Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.

Y J Chen1, C Y Wu, M W Lin, T J Chen, K K Liao, Y C Chen, C Y Hwang, S Y Chu, C C Chen, D D Lee, Y T Chang, W J Wang, H N Liu.   

Abstract

BACKGROUND: Bullous pemphigoid (BP) has been associated with neurological and psychiatric diseases; however, large-scale population-based study of different comorbid diseases in patients with BP is quite limited.
OBJECTIVES: We sought to analyse the prevalence of neurological, psychiatric, autoimmune and inflammatory skin diseases prior to the diagnosis of BP and their associations with BP among patients with BP from a nationwide database in Taiwan.
METHODS: A total of 3485 patients with BP and 17,425 matching controls were identified from the National Health Insurance Database in Taiwan from 1997 to 2008. Conditional logistic regression analyses for a nested case-control study were performed to examine the prevalence of comorbidities prior to the diagnosis of BP between these two groups.
RESULTS: Overall, our results showed that stroke [odds ratio (OR) 3·30; 95% confidence interval (95% CI) 3·03-3·60], dementia (OR 4·81; 95% CI 4·26-5·42), Parkinson disease (OR 3·49; 95% CI 3·05-3·98), epilepsy (OR 3·97; 95% CI 3·28-4·81), schizophrenia (OR 2·56; 95% CI 1·52-4·30) and psoriasis (OR 2·02; 95% CI 1·54-2·66) were significantly associated with BP. Among them, the association with schizophrenia and psoriasis was predominant in female and male patients, respectively, with BP. It remains for all these comorbid diseases to be independently associated with BP by multivariate analysis.
CONCLUSIONS: Patients with BP are more likely to have various neurological diseases, schizophrenia and psoriasis prior to the diagnosis of BP, supporting associations found in other studies. Further research is required to elucidate the tentative causal association with BP.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21517800     DOI: 10.1111/j.1365-2133.2011.10386.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  36 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

2.  A Monocentric Retrospective Observational Study of Comorbidities in Patients Affected by Autoimmune Bullous Diseases.

Authors:  Martina Ferranti; Giulia Gobbo; Giulia Tadiotto Cicogna; Mauro Alaibac
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Authors:  Minhee Kim; Luca Borradori; Dédée F Murrell
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

5.  The coexistence of pemphigus and psoriasis: a systematic review and meta-analysis.

Authors:  Khalaf Kridin; Mouhammad Kridin; Guy Shalom; Arnon D Cohen
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 6.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

7.  Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.

Authors:  Sian-De Liu; Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

8.  Demographics and Autoantibody Profiles of Pemphigoid Patients with Underlying Neurologic Diseases.

Authors:  Kelly N Messingham; Adam D Miller; Nandakumar S Narayanan; Samuel J Connell; Janet A Fairley
Journal:  J Invest Dermatol       Date:  2019-03-12       Impact factor: 8.551

9.  A population-based study of the association between bullous pemphigoid and neurologic disorders.

Authors:  Katherine E Brick; Chad H Weaver; Rodolfo Savica; Christine M Lohse; Mark R Pittelkow; Bradley F Boeve; Lawrence E Gibson; Michael J Camilleri; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-08-29       Impact factor: 11.527

10.  Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180/BP230 brain and skin isoforms.

Authors:  Tamiris A Julio; Sebastian Vernal; Juliana D Massaro; Matheus C Silva; Eduardo A Donadi; Julio C Moriguti; Ana M Roselino
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.